Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Integrated Drug Discovery

Product Image
Product Description

Success in drug discovery depends on a deep understanding of the physiological context of a disease and on the knowledge of the properties that make a molecule into a therapeutically and commercially successful drug.

Our medicinal chemists use synthetic chemistry as a tool to solve problems in biology, pharmacology, and medicine. The experience and creativity of our medicinal chemistry team play a key role in advancing your project and ensuring ultimate success.

Selcia Discovery applies a consultative approach to ensure thorough understanding of the project objectives and deliverable. Key to success is a comprehensive grasp on your requirements and then providing high quality compounds to help you move your project forward.

Our approach can be tailored to the specialist needs of academic institutions and small biotechs where we can be the medicinal chemistry resource supporting you with the following key skills

  • Medicinal chemistry expertise
  • Computational chemistry tools
  • Synthetic excellence ensuring speedy execution of synthesis programmes
  • Patent knowledge
  • In-house biology and in vitro ADME
  • Managing outsourced studies
  • Project management

Product Integrated Drug Discovery
Company Selcia Discovery Services
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Selcia Discovery Services
Fyfield Business & Research Park, Fyfield Road, Ongar, Essex CM5 0GS UK

Tel: +44 (0) 1277 367 000
Fax: +44 (0) 1277 367 099
Email: contact@selcia.com



Scientific News
Making It Personal
Cancer vaccine linked to increased immune response against leukemia cells.
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
First New HIV Vaccine Study for Seven Years Begins
South Africa hosts historic clinical trial of experimental HIV vaccine aiming to safely prevent HIV infection.
Study to Assess Shorter-Duration Antibiotics in Children
Physicians plan a clinical trial to evaluate whether short course anti-biotics are effective at treating CAP in children.
Cancer Gene Predicts Treatment Response in Leukaemia
Study indicates the patients suffering from a lethal for of acute myeloid leukemia may live longer when receiving milder chemotherapy drugs.
Injectable Biologic Therapy Reduces Triglycerides
Study finds first-of-its-kind therapy promising for patients with high triglycerides, cholesterol.
Testing Zika Vaccine in Humans Begins
The first of five planned clinical trials to test ZPIV vaccine in humans has begun.
Combination Therapy Improved Chemoresistance in Ovarian Cancer
The study demonstrates how an existing class of targeted therapies could be used to potentiate the tumor suppression induced by cisplatin.
Gene Therapy for Blistering Skin Disease Shows Promise
Grafting genetically altered skin onto patients’ chronic wounds marks the first time skin-based gene therapy has been demonstrated to be safe and effective in humans.
Scroll Up
Scroll Down

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!